- Molecular NameMethylscopolamine
- SynonymEpoxymethamine Bromide; Epoxytropine Tropate Methylbromide; Hyoscine Methobromide; Hyoscine Methylbromide; Lescopine Bromide; Methoscopylamine Bromide; Methscopolamine; Methscopolamine Methylbromide; Methylscopolamine Bromide; Methylscopolamine Hydrobromide; N-Methylhyoscine Bromide; N-Methylscopolamine Methylsulfate; N-Methylscopolammonium Bromide; Scopolamin Methylbromide; Scopolamine Methobromide; Scopolamine Methylbromide
- Weight318.393
- Drugbank_IDDB00462
- ACS_NO13265-10-6
- Show 2D model
- LogP (experiment)-1.14
- LogP (predicted, AB/LogP v2.0)-1.91
- pkaN/A
- LogD (pH=7, predicted)-1.91
- Solubility (experiment)Soluble
- LogS (predicted, ACD/Labs)(ph=7)-0.17
- LogSw (predicted, AB/LogsW2.0)736.7
- Sw (mg/ml) (predicted, ACD/Labs)214.96
- No.of HBond Donors1
- No.of HBond Acceptors5
- No.of Rotatable Bonds5
- TPSA68.29
- StatusFDA approved
- AdministrationN/A
- PharmacologyAn anticholinergic used in ophthalmology.
- Absorption_value17.5
- Absorption (description)Poorly and unreliably absorbed, total absorption is 10-25%.
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicitySymptoms of a methscopolamine bromide overdose include headache, nausea, vomiting, dry mouth, difficulty swallowing, blurred vision, dilated pupils, hot, dry skin, dizziness; drowsiness, confusion, anxiety, seizures, weak pulse, and an irregular heartbeat. In addition, a curare-like action may occur, i.e., neuromuscular blockade leading to muscular weakness and possible paralysis.
- LD50 (rat)N/A
- LD50 (mouse)N/A